FDA — authorised 20 January 1958
- Marketing authorisation holder: SHIRE
- Status: approved
🇺🇸 Furazol in United States
FDA authorised Furazol on 20 January 1958
Marketing authorisations
FDA — authorised 20 January 1958
- Application: NDA011323
- Marketing authorisation holder: SHIRE
- Local brand name: FUROXONE
- Indication: SUSPENSION — ORAL
- Status: approved
Furazol in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Furazol approved in United States?
Yes. FDA authorised it on 20 January 1958; FDA authorised it on 20 January 1958.
Who is the marketing authorisation holder for Furazol in United States?
SHIRE holds the US marketing authorisation.